Dataset Information

Acetylation profiles in the metabolic process of glioma-associated seizures

ABSTRACT: We used label-free based mass spectrometry-based quantitative proteomics to quantify dynamic changes of protein acetylation between gliomas with seizure (CA1 group) and gliomas without seizure (CA2 group).We further classified acetylated proteins into groups according to cell component, molecular function and biological process. In addition, metabolic pathways and protein interaction networks were analyzed.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Brain

DISEASE(S): Brain Glioma

SUBMITTER: Peisen yao

LAB HEAD: Dezhi Kang

PROVIDER: PXD027864 | Pride | 2022-02-17

REPOSITORIES: Pride

ACCESS DATA

Publications

Acetylation Profiles in the Metabolic Process of Glioma-Associated Seizures.

Xu Ya-Wen YW Lin Peng P Zheng Shu-Fa SF Huang Wen W Lin Zhang-Ya ZY Shang-Guan Huang-Cheng HC Lin Yuan-Xiang YX Yao Pei-Sen PS Kang De-Zhi DZ

Frontiers in neurology 20211001

<b>Objective:</b> We test the hypothesis that lysine acetylation is involved in the metabolic process of glioma-associated seizures (GAS). <b>Methods:</b> We used label-free mass spectrometry-based quantitative proteomics to quantify dynamic changes of protein acetylation between gliomas with seizure (CA1 group) and gliomas without seizure (CA2 group). Furthermore, differences of acetyltransferase and deacetylase expression between CA1 and CA2 groups were performed by a quantitative proteomic st ...[more]

PMID: 34664012

Similar Datasets

Project description:Purpose: Presence of pelvic lymph node metastases is the main prognostic factor in early stage cervical cancer patients, primarily treated with surgery. Aim of this study was to identify cellular tumor pathways associated with pelvic lymph node metastasis in early stage cervical cancer. Experimental Design: Gene expression profiles (Affymetrix U133 plus 2.0) of 20 patients with negative (N0) and 19 with positive lymph nodes (N+), were compared with gene sets that represent all 285 presently available pathway signatures. Validation immunostaining of tumors of 274 consecutive early stage cervical cancer patients was performed for representatives of the identified pathways. Results: Analysis of 285 pathways resulted in identification of five pathways (TGF-β, NFAT, ALK, BAD, and PAR1) that were dysregulated in the N0, and two pathways (β-catenin and Glycosphingolipid Biosynthesis Neo Lactoseries) in the N+ group. Class comparison analysis revealed that five of 149 genes that were most significantly differentially expressed between N0 and N+ tumors (P<0.001) were involved in β-catenin signaling (TCF4, CTNNAL1, CTNND1/p120, DKK3 and WNT5a). Immunohistochemical validation of two well-known cellular tumor pathways (TGF-β and β-catenin) confirmed that the TGF-β pathway (positivity of Smad4) was related to N0 (OR:0.20, 95%CI:0.06-0.66) and the β-catenin pathway (p120 positivity) to N+ (OR:1.79, 95%CI:1.05-3.05). Conclusions: Our study provides new, validated insights in the molecular mechanism of lymph node metastasis in cervical cancer. Pathway analysis of the microarray expression profile suggested that the TGF-β and p120-associated non-canonical β-catenin pathways are important in pelvic lymph node metastasis in early stage cervical cancer. For the microarray experiment, we selected fresh frozen primary cervical cancer tissue, containing at least 80% tumor cells, of patients with histologically confirmed N0 (n=20) and of patients with N+ (n=19). The N0 and N+ groups were matched for age, FIGO stage and histology (all squamous cell carcinoma).

Dataset Information

Acetylation profiles in the metabolic process of glioma-associated seizures

Publications

Acetylation Profiles in the Metabolic Process of Glioma-Associated Seizures.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure